Market revenue in 2023 | USD 686.3 million |
Market revenue in 2030 | USD 422.4 million |
Growth rate | -6.7% (CAGR from 2023 to 2030) |
Largest segment | Hospitals |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care |
Key market players worldwide | Becton Dickinson & Co, BioMerieux SA, Bio-Rad Laboratories Inc, Abbott Laboratories, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Roche Holding AG, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics market will help companies and investors design strategic landscapes.
Hospitals was the largest segment with a revenue share of 47.01% in 2023. Horizon Databook has segmented the Spain molecular diagnostics market based on hospitals, outpatient facilities, home care covering the revenue growth of each sub-segment from 2018 to 2030.
In Spain, under the law of Cohesion and Quality of the Spanish National Health System, new diagnostics are added to the national catalog only after a thorough review of their effectiveness, efficacy, efficiency, and safety. The National Health System’s Interterritorial Council presides over including services and products, while the central government is responsible for pricing.
Molecular diagnostic instruments and service providers are developing novel technologies with improved accuracy, speed, and sensitivity. Genetic testing, coupled with advanced molecular diagnostic devices, is an essential part of clinical diagnosis.
Commonly performed diagnostic tests in the country include HPV testing for cervical cancer, diagnosis of viral load, and detection of genetic regions linked to disorders, such as cancer. Genomica S.A.U is one of the key companies in Spain which actively provides DNA analysis to legal and forensic medicine.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Spain molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account